{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:52:48Z","timestamp":1792608768367,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111209","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T19:19:09Z","timestamp":1415906349000},"page":"e111209","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Incidence of HIV-Associated Tuberculosis among Individuals Taking Combination Antiretroviral Therapy: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Tendesayi","family":"Kufa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonderai","family":"Mabuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evans","family":"Muchiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rosillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation (2013) Global Tuberculosis Report 2013. Geneva, Switzerland. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf<\/ext-link>. Accessed 2014 Jan 16."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"SD Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis","volume":"9","author":"AB Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e34156","DOI":"10.1371\/journal.pone.0034156","article-title":"Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community","volume":"7","author":"A Gupta","year":"2012","journal-title":"PLoS One"},{"key":"ref5","unstructured":"World Health Organisation(2010) Tuberculosis Country Profiles. Available: http:\/\/www.who.int\/tb\/country\/data\/download\/en\/index.html<\/ext-link>. Accessed 2012 May 10."},{"key":"ref6","unstructured":"UNAIDS (2010) HIV estimates with uncertainity bounds 2009. Availble: http:\/\/www.unaids.org\/globalreport\/documents\/HIV_Estimates_GR2010_2009_en.xls<\/ext-link>. Accessed 2012 May 10."},{"key":"ref7","unstructured":"UNAIDS (2012) Adult (15\u201349) HIV prevalence percent by country, 1990\u20132007. Available: data.unaids.org\/pub\/\u2026\/20080813_gr08_prev1549_1990_2007. Accessed 2012 May 10."},{"key":"ref8","unstructured":"World Bank (2012) World Bank Analytical Classifications 1987\u20132010. Available: http:\/\/data.worldbank.org\/about\/country-classifications<\/ext-link>. Accessed 2012 Jul 1."},{"key":"ref9","unstructured":"Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M, et al<\/etal>. (n.d.) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. Available: http:\/\/www.medicine.mcgill.ca\/rtamblyn\/Readings\/The%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf<\/ext-link>. Accessed 2012 May 11."},{"key":"ref10","article-title":"Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study","author":"S Hermans","year":"2012","journal-title":"HIV Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"758350","DOI":"10.1155\/2011\/758350","article-title":"Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART","volume":"2011","author":"W Worodria","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2466-11-26","article-title":"Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995\u20132007","volume":"11","author":"GA Taarnhoj","year":"2011","journal-title":"BMC Pulm Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/QAI.0b013e3182182e2d","article-title":"Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?","volume":"57","author":"AC Pettit","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e318218a713","article-title":"Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs","volume":"57","author":"S Nicholas","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.5588\/ijtld.10.0686","article-title":"Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count","volume":"15","author":"E Martin-Echevarria","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/QAD.0b013e328348fafd","article-title":"Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors","volume":"25","author":"A Kruk","year":"2011","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.5588\/ijtld.10.0788","article-title":"Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania","volume":"15","author":"C Kabali","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/infdis\/jir421","article-title":"Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening","volume":"204","author":"TR Sterling","year":"2011","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","article-title":"Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies","volume":"56","author":"A Van Rie","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","article-title":"Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy","volume":"24","author":"SD Lawn","year":"2010","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/QAD.0b013e32833a2507","article-title":"Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa","volume":"24","author":"S Komati","year":"2010","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-10-23","article-title":"The tuberculosis challenge in a rural South African HIV programme","volume":"10","author":"CF Houlihan","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","article-title":"Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa","volume":"5","author":"SM Hermans","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","article-title":"Body mass index and risk of tuberculosis and death","volume":"24","author":"CF Hanrahan","year":"2010","journal-title":"AIDS"},{"key":"ref25","first-page":"318","article-title":"Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso","volume":"14","author":"M Dembele","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/QAD.0b013e3283366747","article-title":"HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years","volume":"24","author":"S Abgrall","year":"2010","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2334-9-46","article-title":"Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database","volume":"9","author":"J Zhou","year":"2009","journal-title":"BMC Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"SD Lawn","year":"2009","journal-title":"AIDS"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/QAD.0b013e3283320dfd","article-title":"Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?","volume":"23","author":"AD Grant","year":"2009","journal-title":"AIDS"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"JE Golub","year":"2009","journal-title":"AIDS"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1874613600903010063","article-title":"Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal","volume":"3","author":"JF Etard","year":"2009","journal-title":"Open AIDS J"},{"key":"ref32","first-page":"1393","article-title":"Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status","volume":"12","author":"S Moreno","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0037-86822008000600001","article-title":"Tuberculosis incidence and risk factors among patients living with HIV\/AIDS in public health service institutions in Brasilia, Federal District","volume":"41","author":"LH Lannoy","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/QAD.0b013e328311ac4e","article-title":"Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil","volume":"22","author":"JE Golub","year":"2008","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"D Moore","year":"2007","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/QAD.0b013e3282f09876","article-title":"Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa","volume":"21","author":"R Moh","year":"2007","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1371\/journal.pone.0000826","article-title":"Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995\u20132001","volume":"2","author":"A Miranda","year":"2007","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"JE Golub","year":"2007","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"SD Lawn","year":"2006","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-6405-3-10","article-title":"Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients","volume":"3","author":"D Jerene","year":"2006","journal-title":"AIDS Res Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":"Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden","volume":"20","author":"MM Bonnet","year":"2006","journal-title":"AIDS"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"C Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"E Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/135965350300800505","article-title":"Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d'Ivoire","volume":"8","author":"C Seyler","year":"2003","journal-title":"Antivir Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00126334-200312010-00012","article-title":"Recurrence of tuberculosis in HIV-1-infected adults treated after rifamycin-based treatment and highly active antiretroviral therapy","volume":"34","author":"CC Hung","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"M Badri","year":"2002","journal-title":"Lancet"},{"key":"ref48","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group","volume":"4","author":"JL Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1086\/522986","article-title":"Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries","volume":"45","author":"MW Brinkhof","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref50","unstructured":"Rajasekaran S, Raja K, Jeyaseelan L, Vijila S, Priya K, et al<\/etal>. (2009) Post-HAART tuberculosis in adults and adolescents with HIV in India: Incidence, clinical and immunological profile. Indian Journal of Tuberculosis 69\u201376."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2471\/BLT.08.058453","article-title":"Trends in tuberculosis incidence and their determinants in 134 countries","volume":"87","author":"C Dye","year":"2009","journal-title":"Bull World Health Organ"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"S1159","DOI":"10.1093\/infdis\/jir411","article-title":"Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis","volume":"204","author":"SD Lawn","year":"2011","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/01.aids.0000432456.14099.c7","article-title":"Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial","volume":"27","author":"D Laureillard","year":"2013","journal-title":"AIDS"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1086\/595985","article-title":"Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy","volume":"199","author":"YC Manabe","year":"2009","journal-title":"J Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.5588\/ijtld.12.0049","article-title":"Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment","volume":"16","author":"K Middelkoop","year":"2012","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T04:33:58Z","timestamp":1650602038000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111209"}},"subtitle":[],"editor":[{"given":"Robert J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111209","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}